Regulation of actin organisation by TGF-beta in H-ras-transformed fibroblasts.

The actin cytoskeleton undergoes architectural changes during the processes of cell transformation and tumourigenesis. Transforming growth factors beta arrest cell cycle progression, regulate differentiation and modulate the onset of oncogenesis and tumourigenesis. Here, we investigated the direct role of transforming growth factor beta-1 in altering the transformed phenotype and regulating the actin organisation of oncogenic fibroblasts that constitutively or inducibly express the H-ras oncogene. Following transforming growth factor beta-1 treatment, these transformed fibroblasts undergo a dramatic morphological alteration that includes a discrete reorganisation of their actin cytoskeleton and focal adhesions. Quantitative biochemical analysis demonstrated that transforming growth factor beta-1 potently induced polymerisation of globular to filamentous actin, thus corroborating the morphological analysis. The effect of transforming growth factor beta-1 on the cytoskeleton correlates with the ability of this cytokine to suppress anchorage-independent growth of the transformed fibroblasts. Furthermore, transforming growth factor beta-1 upregulates considerably the levels of the RhoB small GTPase and less the RhoA levels. Finally, The beta GTPase inhibitor, C3 exotransferase, blocks the ability of TGF-beta1 to induce cytoskeletal reorganisation. These findings indicate that transforming growth factor beta can regulate cell morphology and growth in a concerted manner possibly via mechanisms that control the actin cytoskeleton.

[1]  C. Der,et al.  Biological assays for cellular transformation. , 1994, Methods in enzymology.

[2]  B. Groner,et al.  The v‐mos and H‐ras oncogene expression represses glucocorticoid hormone‐dependent transcription from the mouse mammary tumor virus LTR. , 1986, The EMBO journal.

[3]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[4]  F. McCormick,et al.  A role for Rho in Ras transformation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Assoian,et al.  Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. , 1997, Current opinion in cell biology.

[6]  S. Sebti,et al.  Disruption of Oncogenic K-Ras4B Processing and Signaling by a Potent Geranylgeranyltransferase I Inhibitor(*) , 1995, The Journal of Biological Chemistry.

[7]  M. Kinch,et al.  Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells. , 1997, Molecular biology of the cell.

[8]  Allan Balmain,et al.  TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice , 1996, Cell.

[9]  H. Lodish,et al.  Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia , 1997 .

[10]  C. Stournaras,et al.  Dexamethasone induces rapid actin assembly in human endometrial cells without affecting its synthesis , 1997, Journal of cellular biochemistry.

[11]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[12]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[13]  H. Moses,et al.  Transforming growth factor type β regulation of actin mRNA , 1986 .

[14]  H. Moses,et al.  RhoB Is Stabilized by Transforming Growth Factor β and Antagonizes Transcriptional Activation* , 1998, The Journal of Biological Chemistry.

[15]  A. Ben-Ze'ev,et al.  Cytoskeletal and adhesion proteins as tumor suppressors. , 1997, Current opinion in cell biology.

[16]  J. Massagué,et al.  Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. , 1996, Cancer surveys.

[17]  N. Tapon,et al.  Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. , 1997, Current opinion in cell biology.

[18]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[19]  D. Häussinger,et al.  Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene. , 1994, European journal of cell biology.

[20]  A. Hall,et al.  The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. , 1989, Biochemical and biophysical research communications.

[21]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[22]  H. Beug,et al.  TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.

[23]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[24]  C. Stournaras,et al.  Na+/Pi co-transport alters rapidly cytoskeletal protein polymerization dynamics in opossum kidney cells. , 1996, The Biochemical journal.

[25]  A. Hall,et al.  Rho- and Rac-dependent Assembly of Focal Adhesion Complexes and Actin Filaments in Permeabilized Fibroblasts: An Essential Role for Ezrin/Radixin/Moesin Proteins , 1997, The Journal of cell biology.

[26]  C. Stournaras,et al.  Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B. , 1996, Biochemical Pharmacology.

[27]  M. Sporn,et al.  Type beta transforming growth factor: a bifunctional regulator of cellular growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Lodish,et al.  The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. , 1993, The Journal of biological chemistry.

[29]  C. Hall,et al.  Regulation of actin cytoskeleton by Rho-family GTPases and their associated proteins , 1996 .

[30]  Luzhe Sun,et al.  Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells* , 1996, The Journal of Biological Chemistry.

[31]  Laura M. Machesky,et al.  Role of Actin Polymerization and Adhesion to Extracellular Matrix in Rac- and Rho-induced Cytoskeletal Reorganization , 1997, The Journal of cell biology.

[32]  P. Adamson,et al.  Intracellular localization of the P21rho proteins , 1992, The Journal of cell biology.

[33]  R. Weinberg,et al.  Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts , 1986, Molecular and cellular biology.

[34]  T. Sakai,et al.  ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. , 1993, Oncogene.

[35]  K. Burridge,et al.  Rho-stimulated contractility drives the formation of stress fibers and focal adhesions , 1996, The Journal of cell biology.

[36]  K. Kinzler,et al.  Frequency of Smad gene mutations in human cancers. , 1997, Cancer research.

[37]  P. Segarini,et al.  Binding of transforming growth factor-beta to cell surface proteins varies with cell type. , 1989, Molecular endocrinology.

[38]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[39]  A. Hall,et al.  Microinjection of recombinant p21rho induces rapid changes in cell morphology , 1990, The Journal of cell biology.

[40]  B. Coomber.  Cytoskeleton in TFG-β- and bFGF-modulated endothelial monolayer repair , 1991 .

[41]  K. Miyazono,et al.  Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. , 1996, Current opinion in cell biology.

[42]  C. Stournaras,et al.  Early alterations of actin cytoskeleton in OK cells by opioids , 1998, Journal of cellular biochemistry.

[43]  C. Stournaras,et al.  Dexamethasone alters rapidly actin polymerization dynamics in human endometrial cells: Evidence for nongenomic actions involving cAMP turnover , 1996, Journal of cellular biochemistry.

[44]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[45]  M. Kitagawa,et al.  Geranylgeranylated Rho Small GTPase(s) Are Essential for the Degradation of p27Kip1 and Facilitate the Progression from G1 to S Phase in Growth-stimulated Rat FRTL-5 Cells* , 1997, The Journal of Biological Chemistry.